Your browser doesn't support javascript.
loading
Tyrosine phosphorylation regulates ERß ubiquitination, protein turnover, and inhibition of breast cancer.
Yuan, Bin; Cheng, Long; Gupta, Kshama; Chiang, Huai-Chin; Gupta, Harshita B; Sareddy, Gangadhara R; Wang, Degeng; Lathrop, Kate; Elledge, Richard; Wang, Pei; McHardy, Stanton; Vadlamudi, Ratna; Curiel, Tyler J; Hu, Yanfen; Ye, Qinong; Li, Rong.
Afiliação
  • Yuan B; Department of Medical Molecular Biology, Beijing Institute of Biotechnology, Collaborative Innovation Center for Cancer Medicine, Beijing, China.
  • Cheng L; Institute of Cancer Stem Cell, Cancer Center, Dalian Medical University, Liaoning, China.
  • Gupta K; Department of Molecular Medicine, University of Texas Health Science Center at San Antonio, San Antonio, TX, USA.
  • Chiang HC; Department of Medical Molecular Biology, Beijing Institute of Biotechnology, Collaborative Innovation Center for Cancer Medicine, Beijing, China.
  • Gupta HB; Department of Molecular Medicine, University of Texas Health Science Center at San Antonio, San Antonio, TX, USA.
  • Sareddy GR; Department of Molecular Medicine, University of Texas Health Science Center at San Antonio, San Antonio, TX, USA.
  • Wang D; Department of Medicine, University of Texas Health Science Center at San Antonio, San Antonio, TX, USA.
  • Lathrop K; Department of Obstetrics and Gynecology, University of Texas Health Science Center at San Antonio, San Antonio, TX, USA.
  • Elledge R; Department of Epidemiology and Biostatistics, University of Texas Health Science Center at San Antonio, San Antonio, TX, USA.
  • Wang P; Department of Medicine, University of Texas Health Science Center at San Antonio, San Antonio, TX, USA.
  • McHardy S; Department of Medicine, University of Texas Health Science Center at San Antonio, San Antonio, TX, USA.
  • Vadlamudi R; Department of Cellular and Structural Biology Cancer Therapy and Research Center, University of Texas Health Science Center at San Antonio, San Antonio, TX, USA.
  • Curiel TJ; Center for Innovative Drug Discovery, University of Texas at San Antonio, San Antonio, TX, USA.
  • Hu Y; Department of Obstetrics and Gynecology, University of Texas Health Science Center at San Antonio, San Antonio, TX, USA.
  • Ye Q; Department of Medicine, University of Texas Health Science Center at San Antonio, San Antonio, TX, USA.
  • Li R; Department of Molecular Medicine, University of Texas Health Science Center at San Antonio, San Antonio, TX, USA.
Oncotarget ; 7(27): 42585-42597, 2016 Jul 05.
Article em En | MEDLINE | ID: mdl-27323858
Assuntos
Palavras-chave
Texto completo
Imprimir
XML
PubMed Links
Buscar no Google

Texto completo: 1 Coleções: 01-internacional Base de dados: MEDLINE Assunto principal: Tirosina / Neoplasias da Mama / Receptor beta de Estrogênio Tipo de estudo: Prognostic_studies Limite: Animals / Female / Humans Idioma: En Revista: Oncotarget Ano de publicação: 2016 Tipo de documento: Article País de afiliação: China
Texto completo
Imprimir
XML
PubMed Links
Buscar no Google

Texto completo: 1 Coleções: 01-internacional Base de dados: MEDLINE Assunto principal: Tirosina / Neoplasias da Mama / Receptor beta de Estrogênio Tipo de estudo: Prognostic_studies Limite: Animals / Female / Humans Idioma: En Revista: Oncotarget Ano de publicação: 2016 Tipo de documento: Article País de afiliação: China